OQROGet OQRO Pro
Insider trade

Tenax Therapeutics (TENX)10% owner bought ~$723K

ADAR1 Capital Management, 10% owner at Tenax Therapeutics, bought ~$723K of Tenax Therapeutics shares.

~$723K
Approx. value · 404K sh @ $1.79
5.26M
Holds after · shares reported
Traded
Aug 31, 2026
Filed
Sep 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 31, 2026Company filing · Form 8-K · ResultsReported its results
  2. Aug 20, 2026Insider · Largest insider buy since 201010% owner purchased ~$360K of TENX shares in the open market
  3. Aug 21, 2026Insider · Largest insider buy since 201010% owner purchased ~$1.27M of TENX shares in the open market
  4. Aug 24, 2026Insider10% owner purchased ~$188K of TENX shares in the open market
  5. Aug 31, 2026 · this disclosureInsider10% owner purchased ~$723K of TENX shares in the open market

What came next

  1. Sep 1, 2026Insider10% owner purchased ~$322K of TENX shares in the open market
  2. Sep 2, 2026Insider10% owner purchased ~$338K of TENX shares in the open market
  3. Sep 3, 2026Insider · Largest insider buy since 201010% owner purchased ~$1.6M of TENX shares in the open market
  4. Sep 11, 2026Insider · 2 peopleInsiders: 2 purchases (~$22K)
  5. Sep 15, 2026InsiderCEO purchased ~$8.8K of TENX shares in the open market
  6. Sep 16, 2026Insider · 3 insiders in a week, 2nd time since 2010Director purchased ~$102K of TENX shares in the open market
  7. Oct 9, 20265% stakeDellora Investments LP reported a passive stake (13G) of 6.4%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Tenax Therapeutics

For Tenax Therapeutics, OQRO holds 11 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TENX page.

Other recent filings by ADAR1 Capital Management, LLC, 10% owner

The full history of ADAR1 Capital Management, LLC, 10% owner is on the profile page.

How this filing works

Other disclosures at Tenax Therapeutics

Everything OQRO holds on this company is on its TENX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data